Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Nephroureterectomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Disease 1 Carcinoma, Transitional Cell 1

Interventions

venetoclax 19 Cyclophosphamide 17 pembrolizumab 15 Dexamethasone 15 Cytarabine 12 fludarabine 11 Azacitidine 11 Gemcitabine 9 pomalidomide 8 glofitamab 7 Rituximab 7 Lenalidomide 7 Carboplatin 7 selinexor 6 Temozolomide 6 Granulocyte Colony-Stimulating Factor 6 fludarabine phosphate 5 daratumumab 5 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Injections 5 Cisplatin 5 zanubrutinib 4 ruxolitinib 4 obinutuzumab 4 carfilzomib 4 Surgical Procedures, Operative 4 Immunotherapy, Adoptive 4 Decitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06169436 2023-12-13

Translational Cancer Observational Protocol

IRCCS San Raffaele

Disease, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡